The European markets have recently shown resilience, with the STOXX Europe 600 Index reaching new highs, driven by robust corporate earnings and a rebound in AI-related stocks. Amid this positive momentum, investors are keenly observing opportunities to identify stocks that may be trading below their estimated value due to market fluctuations or overlooked fundamentals.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| Stille (OM:STIL) | SEK234.00 | SEK462.30 | 49.4% |
| Smart Eye (OM:SEYE) | SEK86.00 | SEK171.92 | 50% |
| Modulight Oyj (HLSE:MODU) | €1.06 | €2.09 | 49.3% |
| Micro Systemation (OM:MSAB B) | SEK89.60 | SEK177.23 | 49.4% |
| Fine Foods & Pharmaceuticals N.T.M (BIT:FF) | €8.24 | €16.07 | 48.7% |
| Dynavox Group (OM:DYVOX) | SEK75.60 | SEK147.50 | 48.7% |
| Deutsche Beteiligungs (XTRA:DBAN) | €21.50 | €42.66 | 49.6% |
| Com.Tel (BIT:CMTL) | €1.88 | €3.69 | 49.1% |
| Appear (OB:APR) | NOK45.10 | NOK88.89 | 49.3% |
| Alimak Group (OM:ALIG) | SEK126.60 | SEK247.78 | 48.9% |
Let's dive into some prime choices out of the screener.
Eurazeo (ENXTPA:RF)
Overview: Eurazeo SE is a private equity and venture capital firm that focuses on growth capital, acquisitions, leveraged buyouts, and investments across various market segments including healthcare, with a market cap of approximately €3.31 billion.
Operations: The firm's revenue from Asset Management Activity amounts to €436 million.
Estimated Discount To Fair Value: 29.7%
Eurazeo SE's recent half-year earnings show a significant reduction in net loss from EUR 308.69 million to EUR 6.34 million, with sales increasing to EUR 211.44 million. The stock trades at approximately 29.7% below its estimated fair value and is valued under future cash flow estimations by over 20%. While its dividend yield of 6.2% lacks coverage by earnings or cash flows, revenue is projected to grow annually at a robust rate of 16.3%.
- Upon reviewing our latest growth report, Eurazeo's projected financial performance appears quite optimistic.
- Dive into the specifics of Eurazeo here with our thorough financial health report.
X-FAB Silicon Foundries (ENXTPA:XFAB)
Overview: X-FAB Silicon Foundries SE develops, produces, and sells analog/mixed-signal ICs, micro-electro-mechanical systems, and silicon photonics products for various sectors including automotive and medical across Europe, the United States, Asia, and internationally with a market cap of €886.34 million.
Operations: The company generates revenue of $846.24 million from its CMOS and MEMS operations, serving sectors such as automotive, medical, industrial, communication, and consumer markets globally.
Estimated Discount To Fair Value: 34.8%
X-FAB Silicon Foundries is trading at €6.79, significantly below its estimated future cash flow value of €10.41, indicating it may be undervalued based on cash flows. Despite a volatile share price and a recent net loss of US$14.83 million for Q2 2026, the company shows strong earnings growth potential at 51.1% annually, outpacing the French market's 13%. However, revenue forecasts are modest at 9.6% per year with declining profit margins from last year’s figures.
- Our earnings growth report unveils the potential for significant increases in X-FAB Silicon Foundries' future results.
- Navigate through the intricacies of X-FAB Silicon Foundries with our comprehensive financial health report here.
OHB (XTRA:OHB)
Overview: OHB SE is a space and technology company operating in Germany, the rest of Europe, and internationally, with a market cap of €5.23 billion.
Operations: The company's revenue is derived from its Space Systems segment, which contributes €1.01 billion, followed by Access to Space at €179.18 million and Digital at €145.10 million.
Estimated Discount To Fair Value: 41.2%
OHB, trading at €248.5, is priced below its estimated future cash flow value of €422.69, highlighting potential undervaluation based on cash flows. Despite recent quarterly losses and high share price volatility, earnings are projected to grow significantly at 33.3% annually over the next three years, surpassing the German market's growth rate. However, debt coverage by operating cash flow remains weak. Strategic partnerships and equity offerings could enhance operational capabilities and financial stability moving forward.
- Our growth report here indicates OHB may be poised for an improving outlook.
- Click here to discover the nuances of OHB with our detailed financial health report.
Key Takeaways
- Delve into our full catalog of 210 Undervalued European Stocks Based On Cash Flows here.
- Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com